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Abstract
In this paper we review some of the best available evidence to argue that screening for perinatal depression should 
be systematically conducted since pregnancy. Our view is organized in ten topics: (1) perinatal depression high 
prevalence; (2) its potential negative consequences, including maternal, conjugal, foetal, infantile, and child effects; 
(3) its under-detection and treatment; (4) its stigma; (5) the professionals and women misconceptions related to 
perinatal depression; (6) the availability of valid and short self-report screening instruments for perinatal depression 
and (7) their acceptability;  (8) the increase in recognition, diagnosis, and treatment rates in comparison with routine 
practice; (9) the opportunity, given the large number of contacts that women have with health professionals in the 
perinatal period; and (10) perinatal depression screening potential cost-effectiveness.
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Introduction
Over the last decades, the scientific literature has accumu-
lated to show that perinatal depression should be consid-
ered a major public health problem [1]. In developed coun-
tries as the UK, Australia, New Zealand, Canada and the 
US, systematic screening programs for perinatal depres-
sion are already being implemented [2-4]. Thus, screening 
and case identification strategies have been advocated, but 
have also attracted substantial controversy [5]. In the fol-
lowing paragraphs we review the best available evidence to 
defend perinatal depression screening, that is, ten reasons 
to detect and treat perinatal depression since pregnancy.
Ten reasons to screen for perinatal depression
First
We should screen for perinatal depression because of its 
high prevalence: although antenatal depression (AD) is less 
well documented than postpartum depression (PPD), it is 
at least as common as PPD and for almost half of women 
it may continue into the postpartum period (e.g. [6, 7]). 
Furthermore, AD is one of the most consistent risk factors 
for PPD [8]. The best point prevalence estimates of major 
depression at different times during pregnancy range from 
3.1% to 4.9%; when minor depression is included, the point 
prevalence range rises from 8.5% to 11.0%. In the post-
partum these figures range from 1.0% to 5.9% and 6.5% 
to 12.9%, respectively [9]. In a recent and rigorous study 
from our team, the prevalence of depressive disorders at 
pregnancy (third trimester) was of 2.3% according to ICD-
10 and of 1.3% according to DSM-IV. Regarding period 
prevalence from delivery to the twelfth month postpartum 
it was of 11.0%/CID-10 and of 8.9%/DSM-IV [10]. While 
estimates of point prevalence of depression at six months 
are similar to those observed at other times in childbearing 
years [9, 11], the incidence of depression is higher in the 
first five weeks postpartum, probably due to the stressful 
effect of childbirth [11]. Additionally, in women with sig-
nificant preexisting mood disorders, the risk of perinatal 
relapse is higher than in any other period [12]. 
Second
Because of the potential negative consequences of AD, 
including maternal, fetal, infantile, and child effects. For 
women, these include non-compliance with prenatal care 
and with healthy life styles [13], spontaneous abortion 
[14], preeclampsia, [15] and complicated deliveries [16].
AD has child immediate effects associated with in-
creased morbidity and mortality in the infant, including 
preterm delivery and lower birth weight [17]. As examples 
of the long-term adverse effects of AD, we can mention 
more difficult infant temperament [18, 19], behavioral and 
emotional problems [20], hyperactivity, poor social skills 
[21] and sleep problems [22] in childhood, and higher risk 
of criminality [23] and depression in adolescence [24]. 
Also very well documented is the negative impact of 
PPD on the entire family [25], from the early difficulties 
in mother-infant relationship [26], and maladaptive care-
taking behaviors and parenting [27], to the infant, toddler 
[28], preadolescent [29] and adolescence [30] social, emo-
tional, and behavioral development. Mother-child interac-
tions in the presence of PPD may be characterized simul-
taneously by hostility and unresponsiveness [31, 32]. Stein 
et al. [33] proposed that a woman’s self-preoccupation and 
rumination may be a critical process in understanding the 
effects of PPD on responsive parenting.
Furthermore, women with depressive symptoms are 
less likely to attend well-child visits, complete immuniza-
tions, use home safety devices and car seats, use recom-
mended practices in putting infants to sleep, and setting 
safe water heater temperature levels [34].
Recent longitudinal studies showed that maternal 
depressive symptoms experienced during the first six 
months postpartum are associated with internalizing and 
externalizing psychopathology from early childhood to 
adolescence [35, 36].
The literature examining the effects of PPD on child 
cognitive development is quite well established, with 
qualitative reviews converging in their conclusions. It is 
consensual that PPD predicts poorer language and IQ de-
velopment in children and that this effect is found across 
childhood and adolescence [28, 37-39].
Because of a depressed mother’s maladaptive caretak-
ing behaviors, her infant’s health may suffer. There is good 
evidence that PPD is associated with poorer child cardio-
vascular functioning [40], gastrointestinal infections and 
lower respiratory tract infections [41]. Finally, other stud-
ies provide evidence that PPD affects child growth [42, 43].
It is also important to mention that PPD undermines 
marital relationships, being high the association between 
PPD and depression in the partner [25].
In summary, like major depression that occurs at oth-
er times in a woman’s life, PPD creates personal suffering 
and diminishes a woman’s ability to function effectively in 
many spheres of her life. What is different is that postpar-
tum women have major responsibility as they are caring 
of a young infant, and ongoing depression interferes with 
parenting and is associated with a variety of negative child 
outcomes at both short and long term [4].
Third
Because of the dramatic under-detection and treatment of 
perinatal depression. Approximately 75% of the cases of 
this treatable condition are not identified by professionals 
(eg. [44, 45]) and without screening programs, only 10% of 
women are treated [46]. This constitutes one of the most 
important and costly public health problems concerning 
perinatal women [47]. 
 
Fourth
The majority of women with PPD symptoms do not seek 
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help from any source [48]. Help-seeking behavior for PPD 
is influenced by a variety of factors, including recognition 
of the problem, available resources, adequate social sup-
port, perceived stigma, and guilty for suffering during a pe-
riod that is supposed to be happy and of fulfillment [49, 50].
Fifth
Because of professionals' [51, 52] and womens' [53] mis-
conceptions about some depressive features. Symptoms, 
such as disturbed sleep, appetite, energy and interest level, 
which are true symptoms of depression may be confused 
with symptoms normally associated with pregnancy and 
postpartum [54].
Sixth
The availability of valid, reliable and economical screen-
ing tools.  The most widely used screening questionnaire 
for PPD is the Edinburgh Postpartum Depression Scale 
(EPDS) [55]. It has only 10 items and it has been translated 
and validated into many languages. The most important 
limitation of the EPDS is the fact that although it was spe-
cifically designed to screen for PPD, all items are similar 
to those from general depression scales, meaning that it 
does not include items about the context of a woman’s ex-
perience as a new mother. Although perinatal depression 
symptomatology is not specific, it is influenced by the par-
ticular situation of being a mother of a newborn  [56] and 
some authors have reported differences between perinatal 
depressive episodes and those that occur in other periods, 
such as, more anxious features, guilty, emotional lability, 
irritability, and concentration/decision-making difficulties 
[54, 57]; irrational worries about the well-being of the in-
fant; and obsessional thoughts of harming themselves or 
their infants are not uncommon [58]. Gibson et al. [59] 
systematically reviewed the published evidence on EPDS 
validity for detecting PPD and AD. Sensitivity, specifici-
ty, and positive predictive values (PPV) of cut-off points 
showed marked heterogeneity between studies. Sensitiv-
ity results ranged from 34 to 100%, specificity from 44 to 
100% and PPV from 9 to 64%. 
Although NICE guidance published in 2007 [60] rec-
ommended the use of the Whooley questions (depressed 
feelings and loss of interest in activities; if “yes” to either 
question, a third question about the need for help), few or 
no evidence could be found of their validity, acceptabili-
ty, clinical effectiveness and cost-effectiveness in perinatal 
women [5]. There is only a recent study [61] showing that 
the two case-finding questions had a sensitivity of approxi-
mately 95% and a specificity of approximately 70%, both in 
pregnancy and postpartum. Among women who screened 
positive antenatally, the third question about the need for 
help had a sensitivity of 58% and a specificity of 90%, with 
lower sensitivity and higher specificity postnatally. The 
authors concluded that negative responses to both of the 
case-finding questions showed acceptable accuracy for rul-
ing out perinatal depression and that for positive respons-
es, the use of a third question about the need for help, im-
proved specificity and the ability to rule in depression.
The Postpartum Depression Screening Scale (PDSS) 
[62] was developed to overcome those and other method-
ological limitations of the EPDS and of other instruments 
widely used to screen for PPD, namely the Beck Depres-
sion Inventory-I [63] and II [64]. In comparison with these 
instruments, PDSS achieved the best combination of sensi-
tivity and specificity in screening for PPD [65]. The sound 
psychometric and operative characteristics of PDSS have 
been corroborated by other versions, such as the Spanish 
(for Hispanic women in the US) [66], the Thai [67], the 
Brazilian [68], and the Turkish [69]. The Portuguese PDSS 
version has recently proved to be valid not only for the 
postpartum [70], but also for pregnancy, by slightly adapt-
ing eight of its 35 items [71]. The limitation that is most 
commonly attributed to the PDSS is its length [5]. Mean-
while this has been overcome by the development of PDSS 
short versions. 
Beck and Gable [62] developed a short form version 
(PDSS-SF) that consists of seven items, each one repre-
senting a dimension evaluated by the PDSS. PDSS-SF 
demonstrated equal levels of reliability and validity as the 
35-item PDSS with the advantage of being completed in 
as little as 1-2 minutes. Other short versions composed by 
seven items have demonstrated their accuracy in screening 
for postpartum depression [72, 73] and antenatal depres-
sion [74], with sensitivity, specificity, and predictive pow-
er only slightly lower than the 35-items version.  Recently, 
other short versions have been developed, to use both at 
pregnancy and at the postpartum [75]. The criterion to 
select the items from the Portuguese version of the PDSS 
consisted of retaining those that showed strong factor 
loadings (>0.60), which resulted in 21 items in the postpar-
tum and in 24 items in pregnancy.  The PDSS-21 and the 
PDSS-24 proved to be very similar or even superior to the 
35-items PDSS in reliability and screening ability, which 
led the authors to consider them good alternatives (equally 
valid, but more economic, faster ,and easier to complete) to 
screen for perinatal depression.
Seventh
The acceptability of routine screening with self-report 
instruments from both women and health professionals, 
equally at postpartum and at pregnancy [5].
Eighth
The increase in recognition, diagnosis, and treatment rates, 
more-than-doubling the detection rate in comparison with 
routine practice, in the PPT [44, 76, 77] and in pregnan-
cy [78, 79)]. In fact, there is evidence that if screening is 
combined with a subsequent intervention it may decrease 
depressive symptoms in the perinatal period (eg. [80]). 
A recent cluster randomized trial [81], which included 
family medicine practice sites from around the US, com-
pared a condition that included a regimen of screening, 
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further assessment, medication management or referral, 
and follow-up to a usual care condition for women who 
scored at least 10 on the EPDS and later at least 10 on the 
Patient Health Questionnaire-9 [82]. More than 2000 
women were enrolled between 5 and 12 weeks postpar-
tum. A positive outcome was defined as a five-point drop 
on the Patient Health Questionnaire-9 at 6 and 12 months 
postpartum. Although there was only a trend-level effect 
(p=0.007) at six months, there was a significant effect in fa-
vor of the intervention at 12 months. The authors attribut-
ed their success to the fact that depression was assessed in 
a two-stage process through self-report and because med-
ication management was done within primary care prac-
tices. This trial demonstrated the potential of undertaking 
screening and of follow-up care for PPD in family medi-
cine, a context in which women have an ongoing relation-
ship with their family doctor.
Ninth
Because of the opportunity, given that there is a large 
number of convenient opportunities for routine screening 
in the perinatal period, when the contact with health pro-
fessionals is much increased [83]. 
Unfortunately, there are still many women who do not 
have a primary care physician who routinely manages their 
care and it is common that once the postpartum check-up 
is completed, women will not have regular contact with a 
personal physician until their next pregnancy.  Given this, 
there has been an ongoing debate about whether pedia-
tricians can or should screen mothers for depression and 
facilitate treatment referrals [84]. The results of a recent 
study [85] were optimistic showing that both profession-
als and women present high rates (>85%) of acceptability 
about discussing mental health topics including depres-
sion, at pediatric care visits.
Tenth
Although it is difficult to disentangle the effects of the 
screening component alone from interventions linked 
to a positive screen, there is preliminary evidence that 
perinatal screening using a self-report questionnaire is 
cost-effective [86]. Even though this topic remains con-
troversial, there is some suggestive evidence from a re-
view by the US Preventative Services Task Force [87, 
88] that using formal methods to identify depression can 
become effective when they are accompanied by organi-
zational enhancements of care, involving clinician educa-
tion, support from case managers, or a collaborative care 
approach between specialists and primary care physicians. 
In fact, when the costs are primarily considered, manag-
ing false positives and adopting of a structured interview 
as a confirmatory test for those with a positive test, this 
proves to be cost saving compared to the equivalent strat-
egy without an interview [89]. 
 It is reasonable to say that the costs of doing this would 
be lesser than the indirect costs that come from long term 
implications of marital separation and of the social, educa-
tional and mental health difficulties of children affected by 
parental depression [3].  As a screening program may open 
areas of significant need, the alternative of not identifying 
distressed women also raises ethical issues. In this respect, 
the stigma of mental illness is of concern, but, as Buist et al. 
[3] say it “will not be overcome by ignoring the existence 
of mental illness”.
Conclusion
In 1968, Wilson and Jungner [90] attempted to define the 
well-known screening criteria to guide the selection of con-
ditions that would be suitable for screening, based, among 
other factors, on the capacity to detect the condition at an 
early stage and the availability of an acceptable treatment. 
The classic criteria still upheld today the “gold standard of 
screening assessment” have stood well the test of time (eg. 
[91, 92]). The 10 reasons presented in this review clearly 
show that perinatal depression meets the criteria. 
In conclusion, although there are major challenges in-
herent to the implementation of a screening program, we 
argue that the case for screening outweighs that against, 
mainly because of its high prevalence, deleterious effects in 
the entire family, and efficacious treatment options. How-
ever, it is important to perform it simultaneously with 
public health initiatives to reduce the stigma so enduringly 
affiliated to perinatal depression.
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